Evaluation of harm associated with high dose-range clinical decision support overrides in the intensive care unit.

By AHRQ PSNet in AHRQ
January 23, 2019

Wong A, Rehr C, Seger DL, et al. Drug Saf. 2018 Dec 1; [Epub ahead of print].

Read the full post on AHRQ PSNet

AHRQ PSNet